Progenics Pharmaceuticals, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

Date: April 11, 2012
Pages: 30
Price:
US$ 125.00
License [?]:
Publisher: iCD Research
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P60813310E1EN
Leaflet:

Download PDF Leaflet

Progenics Pharmaceuticals, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report
Synopsis

ICD Research's 'Progenics Pharmaceuticals, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, mergers & acquisitions, key facts, information on products and services, plus information on key news events affecting the company.

Summary

ICD Research's 'Progenics Pharmaceuticals, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report' is a crucial resource for industry executives and anyone looking to access key information about 'Progenics Pharmaceuticals, Inc.'

ICD Research's 'Progenics Pharmaceuticals, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
  • Examines and identifies key information and issues about 'Progenics Pharmaceuticals, Inc.' for business intelligence requirements.
  • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
  • Provides data on company financial performance and competitive benchmarking.
  • The profile also contains information on business operations, company history, mergers & acquisitions, major products and services, prospects, key employees.

Reasons To Buy
  • Quickly enhance your understanding of 'Progenics Pharmaceuticals, Inc.'
  • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
  • Increase business/sales activities by understanding your competitors’ businesses better.
  • Recognize potential partnerships and suppliers.

Key Highlights

Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focused on the development and commercialization of therapeutic products to treat the patients with debilitating conditions and life-threatening diseases. The company is principally into the developing the drugs in the fields of supportive care, virology and oncology. Progenics currently focuses developing RELISTOR (methylnaltrexone bromide) for the treatment of opioid-induced constipation. Furthermore, in the field of oncology, the company focuses on conducting phase one clinical trial of PSMA ADC, for the treatment of prostate cancer. Under the virology segment, Progenics focuses on developing the viral-entry inhibitor PRO 140, to inhibit human immunodeficiency virus (HIV) infection. Progenics is headquartered in Tarrytown, New York, the US.
1 BUSINESS ANALYSIS

1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services

2 ANALYSIS OF KEY PERFORMANCE INDICATORS

2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
  2.2.1 Revenue and Operating Profit
  2.2.2 Asset and Liabilities
  2.2.3 Valuation
2.3 Competitive Benchmarking
  2.3.1 Efficiency
  2.3.2 Capital Expenditure
  2.3.3 Turnover – Inventory and Asset

3 MERGERS & ACQUISITIONS AND PARTNERSHIPS

3.1 M&A and Partnerships Strategy

4 RECENT DEVELOPMENTS

5 SWOT ANALYSIS

5.1 SWOT Analysis - Overview
5.2 Strengths
5.3 Weaknesses
5.4 Opportunities
5.5 Threats

6 COMPANY STATEMENT

7 HISTORY

8 KEY EMPLOYEES

9 KEY EMPLOYEE BIOGRAPHIES

10 APPENDIX

10.1 Methodology
10.2 Ratio Definitions
10.3 Disclaimer

LIST OF TABLES

Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: History
Table 6: Key Employees
Table 7: Key Employee Biographies

LIST OF FIGURES

Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Valuation
Figure 4: Efficiency
Figure 5: Capital Expenditure
Figure 6: Turnover – Inventory and Asset

COMPANIES MENTIONED

Progenics Pharmaceuticals, Inc.

Ask Your Question

Progenics Pharmaceuticals, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: